Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2008-09-25 13:35:24 UTC |
---|
Update Date | 2022-11-30 19:03:54 UTC |
---|
HMDB ID | HMDB0010667 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | PG(18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)) |
---|
Description | PG(18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)) is a phosphatidylglycerol or glycerophospholipid (PG or GP). It is a glycerophospholipid in which a phosphoglycerol moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidylglycerols can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PG(18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)), in particular, consists of one chain of g-linolenic acid at the C-1 position and one chain of a-linolenic acid at the C-2 position. The g-linolenic acid moiety is derived from animal fats, while the a-linolenic acid moiety is derived from seed oils, especially canola and soybean oil. Phosphatidylglycerol is present at a level of 1-2% in most animal tissues, but it can be the second most abundant phospholipid in lung surfactant at up to 11% of the total. It is well established that the concentration of phosphatidylglycerol increases during fetal development. Phosphatidylglycerol may be present in animal tissues merely as a precursor for diphosphatidylglycerol (cardiolipin). Phosphatidylglycerol is formed from phosphatidic acid by a sequence of enzymatic reactions that proceeds via the intermediate, cytidine diphosphate diacylglycerol (CDP-diacylglycerol). Bioynthesis proceeds by condensation of phosphatidic acid and cytidine triphosphate with elimination of pyrophosphate via the action of phosphatidate cytidyltransferase (or CDP-synthase). CDP-diacylglycerol then reacts with glycerol-3-phosphate via phosphatidylglycerophosphate synthase to form 3-sn-phosphatidyl-1'-sn-glycerol 3'-phosphoric acid, with the release of cytidine monophosphate (CMP). Finally, phosphatidylglycerol is formed by the action of specific phosphatases. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PGs have a net charge of -1 at physiological pH and are found in high concentration in mitochondrial membranes and as components of pulmonary surfactant. PG also serves as a precursor for the synthesis of cardiolipin. PG is synthesized from CDP-diacylglycerol and glycerol-3-phosphate. |
---|
Structure | [H][C@](O)(CO)COP(O)(=O)OC[C@@]([H])(COC(=O)CCCC\C=C/C\C=C/C\C=C/CCCCC)OC(=O)CCCCCCC\C=C/C\C=C/C\C=C/CC InChI=1S/C42H71O10P/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-31-33-41(45)49-37-40(38-51-53(47,48)50-36-39(44)35-43)52-42(46)34-32-30-28-26-24-22-20-18-16-14-12-10-8-6-4-2/h6,8,11-14,17-20,23,25,39-40,43-44H,3-5,7,9-10,15-16,21-22,24,26-38H2,1-2H3,(H,47,48)/b8-6-,13-11-,14-12-,19-17-,20-18-,25-23-/t39-,40+/m0/s1 |
---|
Synonyms | Value | Source |
---|
1-(6Z,9Z,12Z-Octadecatrienoyl)-2-(9Z,12Z,15Z-octadeatrienoyl)-sn-glycero-3-phospho-(1'-glycerol) | HMDB | 1-g-Linolenoyl-2-a-linolenoyl-sn-glycero-3-phosphoglycerol | HMDB | 1-gamma-Linolenoyl-2-alpha-linolenoyl-sn-glycero-3-phosphoglycerol | HMDB | GPG(18:3/18:3) | HMDB | GPG(18:3N6/18:3N3) | HMDB | GPG(18:3W6/18:3W3) | HMDB | GPG(36:6) | HMDB | PG(18:3/18:3) | HMDB | PG(18:3N6/18:3N3) | HMDB | PG(18:3W6/18:3W3) | HMDB | PG(36:6) | HMDB | Phosphatidylglycerol(18:3/18:3) | HMDB | Phosphatidylglycerol(18:3n6/18:3n3) | HMDB | Phosphatidylglycerol(18:3W6/18:3W3) | HMDB | Phosphatidylglycerol(36:6) | HMDB | 1-(6Z,9Z,12Z-Octadecatrienoyl)-2-(9Z,12Z,15Z-octadeatrienoyl)-sn-glycero-3-phosphoglycerol | HMDB | PG(18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)) | Lipid Annotator |
|
---|
Chemical Formula | C42H71O10P |
---|
Average Molecular Weight | 766.9809 |
---|
Monoisotopic Molecular Weight | 766.478485004 |
---|
IUPAC Name | [(2S)-2,3-dihydroxypropoxy][(2R)-3-[(6Z,9Z,12Z)-octadeca-6,9,12-trienoyloxy]-2-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyloxy]propoxy]phosphinic acid |
---|
Traditional Name | (2S)-2,3-dihydroxypropoxy(2R)-3-[(6Z,9Z,12Z)-octadeca-6,9,12-trienoyloxy]-2-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyloxy]propoxyphosphinic acid |
---|
CAS Registry Number | Not Available |
---|
SMILES | [H][C@](O)(CO)COP(O)(=O)OC[C@@]([H])(COC(=O)CCCC\C=C/C\C=C/C\C=C/CCCCC)OC(=O)CCCCCCC\C=C/C\C=C/C\C=C/CC |
---|
InChI Identifier | InChI=1S/C42H71O10P/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-31-33-41(45)49-37-40(38-51-53(47,48)50-36-39(44)35-43)52-42(46)34-32-30-28-26-24-22-20-18-16-14-12-10-8-6-4-2/h6,8,11-14,17-20,23,25,39-40,43-44H,3-5,7,9-10,15-16,21-22,24,26-38H2,1-2H3,(H,47,48)/b8-6-,13-11-,14-12-,19-17-,20-18-,25-23-/t39-,40+/m0/s1 |
---|
InChI Key | DNEIBWIGGRQBMO-RYYNODHJSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as phosphatidylglycerols. These are glycerophosphoglycerols in which two fatty acids are bonded to the 1-glycerol moiety through ester linkages. As is the case with diacylglycerols, phosphatidylglycerols can have many different combinations of fatty acids of varying lengths and saturation attached to the C-1 and C-2 positions. |
---|
Kingdom | Organic compounds |
---|
Super Class | Lipids and lipid-like molecules |
---|
Class | Glycerophospholipids |
---|
Sub Class | Glycerophosphoglycerols |
---|
Direct Parent | Phosphatidylglycerols |
---|
Alternative Parents | |
---|
Substituents | - 1,2-diacylglycerophosphoglycerol
- Fatty acid ester
- Dialkyl phosphate
- Dicarboxylic acid or derivatives
- Organic phosphoric acid derivative
- Phosphoric acid ester
- Alkyl phosphate
- Fatty acyl
- 1,2-diol
- Carboxylic acid ester
- Secondary alcohol
- Carboxylic acid derivative
- Organic oxide
- Organooxygen compound
- Alcohol
- Organic oxygen compound
- Primary alcohol
- Carbonyl group
- Hydrocarbon derivative
- Aliphatic acyclic compound
|
---|
Molecular Framework | Aliphatic acyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Naturally occurring processBiological processBiochemical pathwayMetabolic pathway- Cardiolipin Biosynthesis CL(18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)/18:3(9Z,12Z,15Z)/18:3(9Z,12Z,15Z)) (PathBank: SMP0082050)
- Cardiolipin Biosynthesis CL(18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)/18:3(9Z,12Z,15Z)/20:0) (PathBank: SMP0082051)
- Cardiolipin Biosynthesis CL(18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)/18:3(9Z,12Z,15Z)/20:1(11Z)) (PathBank: SMP0082052)
- Cardiolipin Biosynthesis CL(18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)/18:3(9Z,12Z,15Z)/20:1(13Z)) (PathBank: SMP0082053)
- Cardiolipin Biosynthesis CL(18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)/18:3(9Z,12Z,15Z)/22:0) (PathBank: SMP0082054)
- Cardiolipin Biosynthesis CL(18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)/18:3(9Z,12Z,15Z)/22:1(13Z)) (PathBank: SMP0082055)
- Cardiolipin Biosynthesis CL(18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)/20:0/20:0) (PathBank: SMP0082056)
- Cardiolipin Biosynthesis CL(18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)/20:0/20:1(11Z)) (PathBank: SMP0082057)
- Cardiolipin Biosynthesis CL(18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)/20:0/20:1(13Z)) (PathBank: SMP0082058)
- Cardiolipin Biosynthesis CL(18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)/20:0/22:0) (PathBank: SMP0082059)
- Cardiolipin Biosynthesis CL(18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)/20:0/22:1(13Z)) (PathBank: SMP0082060)
- Cardiolipin Biosynthesis CL(18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)/20:1(11Z)/20:1(11Z)) (PathBank: SMP0082061)
- Cardiolipin Biosynthesis CL(18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)/20:1(11Z)/20:1(13Z)) (PathBank: SMP0082062)
- Cardiolipin Biosynthesis CL(18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)/20:1(11Z)/22:0) (PathBank: SMP0082063)
- Cardiolipin Biosynthesis CL(18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)/20:1(11Z)/22:1(13Z)) (PathBank: SMP0082064)
- Cardiolipin Biosynthesis CL(18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)/20:1(13Z)/20:1(13Z)) (PathBank: SMP0082065)
- Cardiolipin Biosynthesis CL(18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)/20:1(13Z)/22:0) (PathBank: SMP0082066)
- Cardiolipin Biosynthesis CL(18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)/20:1(13Z)/22:1(13Z)) (PathBank: SMP0082067)
- Cardiolipin Biosynthesis CL(18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)/22:0/22:0) (PathBank: SMP0082068)
- Cardiolipin Biosynthesis CL(18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)/22:0/22:1(13Z)) (PathBank: SMP0082069)
- Cardiolipin Biosynthesis CL(18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)/22:1(13Z)/22:1(13Z)) (PathBank: SMP0082070)
- Cardiolipin Biosynthesis CL(18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)/18:3(9Z,12Z,15Z)/20:3(5Z,8Z,11Z)) (PathBank: SMP0086425)
- Cardiolipin Biosynthesis CL(18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)/18:3(9Z,12Z,15Z)/20:3(8Z,11Z,14Z)) (PathBank: SMP0086426)
- Cardiolipin Biosynthesis CL(18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)/18:3(9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z)) (PathBank: SMP0086427)
- Cardiolipin Biosynthesis CL(18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)/18:3(9Z,12Z,15Z)/20:4(8Z,11Z,14Z,17Z)) (PathBank: SMP0086428)
- Cardiolipin Biosynthesis CL(18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)/18:3(9Z,12Z,15Z)/20:5(5Z,8Z,11Z,14Z,17Z)) (PathBank: SMP0086429)
- Cardiolipin Biosynthesis CL(18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)/20:0/20:3(5Z,8Z,11Z)) (PathBank: SMP0086431)
- Cardiolipin Biosynthesis CL(18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)/20:0/20:3(8Z,11Z,14Z)) (PathBank: SMP0086432)
- Cardiolipin Biosynthesis CL(18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)/20:0/20:4(5Z,8Z,11Z,14Z)) (PathBank: SMP0086433)
- Cardiolipin Biosynthesis CL(18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)/20:0/20:4(8Z,11Z,14Z,17Z)) (PathBank: SMP0086434)
- Cardiolipin Biosynthesis CL(18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)/20:0/20:5(5Z,8Z,11Z,14Z,17Z)) (PathBank: SMP0086435)
- Cardiolipin Biosynthesis CL(18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)/20:3(5Z,8Z,11Z)/20:3(5Z,8Z,11Z)) (PathBank: SMP0086436)
- Cardiolipin Biosynthesis CL(18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)/20:3(5Z,8Z,11Z)/20:3(8Z,11Z,14Z)) (PathBank: SMP0086437)
- Cardiolipin Biosynthesis CL(18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)/20:3(5Z,8Z,11Z)/20:4(5Z,8Z,11Z,14Z)) (PathBank: SMP0086439)
- Cardiolipin Biosynthesis CL(18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)/20:3(5Z,8Z,11Z)/20:4(8Z,11Z,14Z,17Z)) (PathBank: SMP0086440)
- Cardiolipin Biosynthesis CL(18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)/20:3(5Z,8Z,11Z)/20:5(5Z,8Z,11Z,14Z,17Z)) (PathBank: SMP0086441)
- Cardiolipin Biosynthesis CL(18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)/20:3(8Z,11Z,14Z)/20:3(8Z,11Z,14Z)) (PathBank: SMP0086442)
- Cardiolipin Biosynthesis CL(18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)/20:3(8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) (PathBank: SMP0086443)
- Cardiolipin Biosynthesis CL(18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)/20:3(8Z,11Z,14Z)/20:4(8Z,11Z,14Z,17Z)) (PathBank: SMP0086444)
- Cardiolipin Biosynthesis CL(18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)/20:3(8Z,11Z,14Z)/20:5(5Z,8Z,11Z,14Z,17Z)) (PathBank: SMP0086445)
- Cardiolipin Biosynthesis CL(18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) (PathBank: SMP0086446)
- Cardiolipin Biosynthesis CL(18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z)/20:4(8Z,11Z,14Z,17Z)) (PathBank: SMP0086447)
- Cardiolipin Biosynthesis CL(18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z)/20:5(5Z,8Z,11Z,14Z,17Z)) (PathBank: SMP0086448)
- Cardiolipin Biosynthesis CL(18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)/20:4(8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z)) (PathBank: SMP0086449)
- Cardiolipin Biosynthesis CL(18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)/20:4(8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z)) (PathBank: SMP0086450)
- Cardiolipin Biosynthesis CL(18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)/20:5(5Z,8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z)) (PathBank: SMP0086451)
|
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedMetabolite | SMILES | Kovats RI Value | Column Type | Reference |
---|
PG(18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)) | [H][C@](O)(CO)COP(O)(=O)OC[C@@]([H])(COC(=O)CCCC\C=C/C\C=C/C\C=C/CCCCC)OC(=O)CCCCCCC\C=C/C\C=C/C\C=C/CC | 5378.3 | Standard polar | 33892256 | PG(18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)) | [H][C@](O)(CO)COP(O)(=O)OC[C@@]([H])(COC(=O)CCCC\C=C/C\C=C/C\C=C/CCCCC)OC(=O)CCCCCCC\C=C/C\C=C/C\C=C/CC | 4556.9 | Standard non polar | 33892256 | PG(18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)) | [H][C@](O)(CO)COP(O)(=O)OC[C@@]([H])(COC(=O)CCCC\C=C/C\C=C/C\C=C/CCCCC)OC(=O)CCCCCCC\C=C/C\C=C/C\C=C/CC | 5403.0 | Semi standard non polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - PG(18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)) GC-MS (TMS_1_1) - 70eV, Positive | Not Available | 2021-10-18 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - PG(18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)) GC-MS (TMS_1_2) - 70eV, Positive | Not Available | 2021-10-18 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - PG(18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)) GC-MS (TMS_1_3) - 70eV, Positive | Not Available | 2021-10-18 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - PG(18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)) GC-MS (TBDMS_1_1) - 70eV, Positive | Not Available | 2021-10-18 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - PG(18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)) GC-MS (TBDMS_1_2) - 70eV, Positive | Not Available | 2021-10-18 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - PG(18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)) GC-MS (TBDMS_1_3) - 70eV, Positive | Not Available | 2021-10-18 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - PG(18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)) 10V, Positive-QTOF | splash10-02bk-5162831900-fcae7458dbddf40aad90 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - PG(18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)) 20V, Positive-QTOF | splash10-06vs-8294734300-8a90f4bb6aa54a951c12 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - PG(18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)) 40V, Positive-QTOF | splash10-0ar0-9046330000-8d5b985a8c3cb26fd3c2 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - PG(18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)) 10V, Negative-QTOF | splash10-0ar0-1190211400-6f993a4c07cf7ea81be2 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - PG(18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)) 20V, Negative-QTOF | splash10-004i-5290201000-0aca48e28a6c606f2092 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - PG(18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)) 40V, Negative-QTOF | splash10-004i-9010100000-64d9db9b44fd27c6054f | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - PG(18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)) 10V, Negative-QTOF | splash10-014i-0000000900-fd791075be958a612b25 | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - PG(18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)) 20V, Negative-QTOF | splash10-0190-0190310900-ef027ae36a0ad7381f43 | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - PG(18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)) 40V, Negative-QTOF | splash10-0190-0390310900-04edfbe9f2864c41466a | 2021-09-24 | Wishart Lab | View Spectrum |
|
---|